Brief: Bioxyne Records Qtrly Sales Revenue A$0.5 Million
31/10/2022 01:27
Oct 31 (Reuters) - Bioxyne Ltd BXN.AX :
* QTRLY SALES REVENUE A$0.5 MILLION VERSUS A$0.8 MILLION
Further company coverage: BXN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BLS Pharmaceuticals
See all newsBrief: Bioxyne Secures A$50M Exclusive German Supply Agreement With Adrex
Australia's Bioxyne rises to near 8-year high after company secures German supply deal
Australia's Bioxyne at two-week high on supply deal with Remidose LATAM
Brief: Bioxyne Expands LATAM Footprint First Supply Agreement Costa Rica
Australia's Bioxyne hits nearly 8-year high on cannabis firm deal